Acne is a large and attractive market given:
- Approximately 5 million U.S. patients with significant acne seek physician treatment, representing a target market exceeding $1 billion.
- Over $3 billion is spent annually on prescription acne therapy.
- Efficacy of current treatments is decreasing as antibiotic resistance now exceeds 50%.
- The patient population is highly motivated with demonstrated willingness to self-pay for uninsured treatments.